GlassScriptPhysician profile
Dhaval Bhavsar
NPI 1184852808
$2,124.58
in general payments reported to CMS, 2019-2025
14 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $92.43 · 2022: $430 · 2023: $186 · 2024: $731 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $302.46 | 2022 | |
| Avita Medical Americas, LLC | $301.83 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Smith+Nephew, INC. | $261.09 | 2020-2024 | Oasis |
| Polynovo North America LLC | $245.77 | 2022-2024 | Novosorb Btm |
| Rti Surgical, INC | $220.08 | 2025 | |
| Vericel Corporation | $219.97 | 2019-2024 | Nexobrid |
| Musculoskeletal Transplant Foundation INC. | $134.10 | 2024 | |
| Tela Bio, INC. | $121.80 | 2019 | |
| Baxter Healthcare | $108.54 | 2019 | |
| Aroa Biosurgery Incorporated | $96.56 | 2024 | |
| Polarityte, INC. | $47.75 | 2019 | |
| Mentor Worldwide LLC | $35.38 | 2023 | Artoura Breast Tissue Expander |
| Medline Industries LP | $29.25 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhaval Bhavsar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.